Protect the killer: CTLs need defenses against the tumor.
Freeman
Gordon J
GJ
Sharpe
Arlene H
AH
Kuchroo
Vijay K
VK
D000818:Animals; D015703:Antigens, CD; D000954:Antigens, Surface / Q000276:immunology / Q000378:metabolism; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins; D018122:B7-1 Antigen / Q000276:immunology / Q000378:metabolism*; D060890:B7-H1 Antigen; D001798:Blood Proteins; D006801:Humans; D008562:Membrane Glycoproteins; D051379:Mice; D018448:Models, Immunological; D009369:Neoplasms / Q000276:immunology*; D010455:Peptides; D061026:Programmed Cell Death 1 Receptor; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D019139:Tumor Escape
D015703:Antigens, CD; D000954:Antigens, Surface; D051017:Apoptosis Regulatory Proteins; D018122:B7-1 Antigen; D060890:B7-H1 Antigen; D001798:Blood Proteins; C423236:CD274 protein, human; C498919:Cd274 protein, mouse; D008562:Membrane Glycoproteins; C105992:PDCD1 protein, human; C491383:Pdcd1 protein, mouse; D010455:Peptides; D061026:Programmed Cell Death 1 Receptor